The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society’s initiatives and working groups focus on improving the antibody field. We create opportunities for education and networking; monitor and report advances in the commercial pipeline of antibody therapeutics; create standards for characterizing antibody and T-cell receptor repertoires; and engage government and international agencies on matters concerning the antibody community. Please join us!
ADC Review / Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international, peer-reviewed, online journal covering antibody-drug conjugates, biSpecific antibodies, site-specific antibody-drug conjugates, small-molecule drug conjugates and engineered fragments. We invite you to join our community of over 16,000 professionals in Large Drug Development (Pharma / Biotech), Small & Medium Drug Development, Equipment Manufacturers, Contract Development & Manufacturing Organizations, Regulatory & Government Agencies, Platform Technology and Academia.